Blood Collection Tubes

Blood Collection Tubes Manufacturing and Regulatory Compliance in South Africa

What are blood collection tubes (BCTs)?

Blood Collection Tubes (BCTs) are vacuum-sealed containers used for drawing and storing blood samples for diagnostic testing. They are color-coded based on the additive inside (e.g., EDTA, heparin, clot activators), which preserves the blood sample for specific lab tests.

These tubes are critical for: 

  • Clinical diagnostics 
  • Pathology laboratories 
  • Blood banks 
  • Research institutions

Looking for Medical Device Manufacturing Consultant

Blood Collection Tubes Manufacturing Process

The BCT manufacturing process involves: 

  • Injection molding of medical-grade plastic 
  • Additive filling (e.g., anticoagulants) 
  • Vacuum sealing 
  • Sterilization (typically via ethylene oxide or gamma rays) 
  • Packaging in sterile conditions 

Manufacturers must maintain a Class 100k cleanroom environment, adhere to ISO 13485:2016, and conduct quality control tests such as vacuum integrity, additive performance, and shelf-life testing.

BCT Regulatory Requirements in South Africa

South Africa’s medical device regulation is overseen by the South African Health Products Regulatory Authority (SAHPRA). Blood Collection Tubes are classified as Class B medical devices requiring moderate regulatory scrutiny. 

  1. SAHPRA Establishment Licensing

To manufacture or distribute BCTs in South Africa, companies must obtain an SAHPRA Medical Device Establishment License. This covers: 

  • Manufacturing 
  • Importing 
  • Distribution 
  1. Product Classification and Registration

Though full product registration for Class B devices is rolling out gradually, manufacturers must: 

  • Justify risk classification 
  • Provide a Device Master File 
  • Show ISO 13485 certification 
  • Supply clinical or performance evidence 
  1. Quality and Compliance Standards

Manufacturing must follow: 

  1. Labelling and Traceability

Labels must include: 

  • Product name and type 
  • Additive information 
  • Manufacturer details 
  • Batch number, expiry date 
  • Language: English (with local languages encouraged) 
  1. Post-Market Surveillance

SAHPRA requires a post-market surveillance system for monitoring adverse events, recalls, and performance in the field.

Challenges of Setting Up a BCT Manufacturing Unit

Launching a BCT plant involves: 

  • High upfront capital for infrastructure and equipment 
  • Regulatory complexity and documentation 
  • Skilled workforce recruitment 
  • Facility validation and inspection readiness 

Without expert guidance, this can delay market entry and increase non-compliance risk.

Role of Operon Strategist: BCT Manufacturing & Regulatory Consultant

Operon Strategist is a trusted consulting partner for medical device manufacturers across Africa, including South Africa. They specialize in regulatory compliance, plant setup, and ISO implementation for Blood Collection Tube projects. 

Operon Strategist Services Include: 

Turnkey Manufacturing Setup 

  • Facility layout as per GMP & ISO standards 
  • Cleanroom design and equipment selection 
  • Process flow optimization for BCT lines 

SAHPRA Regulatory Consulting 

  • Establishment license application 
  • BCT classification and documentation 
  • Technical file preparation and review 

QMS & ISO 13485 Certification Support 

  • End-to-end ISO 13485 implementation 
  • SOP creation for manufacturing & quality 
  • Internal audit and inspection readiness 

Post-Market Compliance & Staff Training 

  • Pharmacovigilance systems setup 
  • On-site and remote team training 
  • Risk management and recall protocol 

With 15+ years of expertise, Operon Strategist reduces compliance risks and accelerates time-to-market for blood collection tube manufacturers.

Why Local BCT Manufacturing Matters in South Africa

  • Reduces reliance on imported products 
  • Strengthens national healthcare capacity 
  • Boosts local job creation and GDP 
  • Aligns with the government’s MedTech localization goals

FAQ

Manufacturers must comply with SAHPRA regulations for medical devices and IVD products, implement an ISO 13485-compliant quality management system, establish risk management in accordance with ISO 14971, prepare technical documentation, perform product validation where applicable, and obtain the required regulatory approvals before marketing blood collection tubes in South Africa.

Yes. Blood collection tubes intended for collecting, preserving, transporting, or preparing human specimens for diagnostic testing are generally regulated as in vitro diagnostic (IVD) medical devices and must comply with applicable SAHPRA regulatory requirements.

Manufacturers commonly implement ISO 13485 for quality management systems, ISO 14971 for risk management, and ISO 6710, which specifies requirements for single-use containers used for venous blood specimen collection. Additional standards may apply depending on the product design, intended use, and sterilization method.

Manufacturers typically need technical documentation, ISO 13485 certification, ISO 14971 risk management files, ISO 6710 compliance evidence where applicable, performance evaluation data, labeling, manufacturing information, sterilization validation reports (for sterile products), and other supporting documentation required by SAHPRA.